4//SEC Filing
Balcom Alexandra 4
Accession 0001193125-25-288317
CIK 0001861560other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:14 PM ET
Size
27.6 KB
Accession
0001193125-25-288317
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Balcom Alexandra
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2025-11-18$103.61/sh−220$22,794→ 62,243 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-18−729→ 33,646 totalExercise: $72.35Exp: 2034-01-05→ Class A Common Stock (729 underlying) - Sale
Class A Common Stock
2025-11-17$103.27/sh−5,055$522,030→ 62,114 total - Sale
Class A Common Stock
2025-11-18$104.54/sh−509$53,211→ 61,734 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-17−6,875→ 29,101 totalExercise: $6.89Exp: 2031-04-29→ Class A Common Stock (6,875 underlying) - Exercise/Conversion
Class A Common Stock
2025-11-17$6.89/sh+6,875$47,369→ 68,609 total - Sale
Class A Common Stock
2025-11-17$95.12/sh−3,266$310,662→ 74,859 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-17−13,125→ 34,375 totalExercise: $72.35Exp: 2034-01-05→ Class A Common Stock (13,125 underlying) - Exercise/Conversion
Class A Common Stock
2025-11-17$72.35/sh+13,125$949,594→ 81,734 total - Sale
Class A Common Stock
2025-11-17$93.80/sh−3,609$338,524→ 78,125 total - Sale
Class A Common Stock
2025-11-17$100.58/sh−4,496$452,208→ 70,363 total - Sale
Class A Common Stock
2025-11-17$103.68/sh−380$39,398→ 61,734 total - Exercise/Conversion
Class A Common Stock
2025-11-18$72.35/sh+729$52,743→ 62,463 total - Sale
Class A Common Stock
2025-11-17$102.13/sh−3,194$326,203→ 67,169 total
Footnotes (11)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
- [F10]The shares underlying this option vest as follows: 25% of the shares vested on April 29, 2022, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
- [F11]The shares underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.73 to $94.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.93 to $95.58, inclusive.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.11 to $101.07, inclusive.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.57 to $102.47, inclusive.
- [F6]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.60 to $103.54, inclusive.
- [F7]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.65 to $103.79, inclusive.
- [F8]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.14 to $103.96, inclusive.
- [F9]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.25 to $105.12, inclusive.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
Related Parties
1- filerCIK 0001862147
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 5:14 PM ET
- Size
- 27.6 KB